Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Background<p>Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor prognosis. Efferocytosis, an essential process for clearing apoptotic cells, is involved in shaping immunosuppressive microenvironment, facilitating tumor immune evasion. This study aims to evaluate the...

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Xiangjun Wang (2522917) (author)
Diğer Yazarlar:	Wei Wang (17594) (author), Chuanxin Yang (18266948) (author), Puxiongzhi Wang (3877201) (author), Yangming Liu (12254459) (author), Liqin Yu (1461880) (author), Sijie Zhang (7429373) (author), Xiaoyu Yan (500545) (author), Jian Wang (5901) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Genetic Immunology pancreatic ductal adenocarcinoma efferocytosis prognostic signature immunosuppressive microenvironment P2RY6 MRS-2578
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 5_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Image 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
Yazar:: Xiangjun Wang (2522917)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
Yazar:: Gregory L. Beatty (15087193)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 2 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
Yazar:: Gregory L. Beatty (15087193)
Baskı/Yayın Bilgisi: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
Yazar:: Marwa Zafarullah (12527002)
Baskı/Yayın Bilgisi: (2025)

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
Yazar:: Jichang Liu (1263291)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 3_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.pdf
Yazar:: Ping Liao (5424887)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.docx
Yazar:: Ping Liao (5424887)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 2_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.xls
Yazar:: Ping Liao (5424887)
Baskı/Yayın Bilgisi: (2025)

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx
Yazar:: Yanju Li (9697993)
Baskı/Yayın Bilgisi: (2025)

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
Yazar:: Rui Wang (52434)
Baskı/Yayın Bilgisi: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
Yazar:: Rui Wang (52434)
Baskı/Yayın Bilgisi: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
Yazar:: Rui Wang (52434)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
Yazar:: Erika Y. Faraoni (14844897)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
Yazar:: Erika Y. Faraoni (14844897)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
Yazar:: Erika Y. Faraoni (14844897)
Baskı/Yayın Bilgisi: (2025)

الإثبات بالتوقيع الرقمي في العقود الذكيّة باستخدام تقنية البلوك تشين بين الفقه الإسلامي وقانون المعاملات الإلكترونيّة الأردني وقانون البينات
Yazar:: Daoud, Hayel Abdel Hafeez Yousef
Baskı/Yayın Bilgisi: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_uuo65s6n2892p28endkg9352td